Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > What, if anything, is the FDA Doing?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(21)
•••
Comment by echo2on May 01, 2018 9:42am
161 Views
Post# 27963577

RE:RE:RE:RE:RE:RE:RE:What, if anything, is the FDA Doing?

RE:RE:RE:RE:RE:RE:RE:What, if anything, is the FDA Doing?Just FYI, the scientist who developed and refined the Ozone + H2O2 technology at TSO3 did excellent, ground-breaking work,  helping to establish TSO3's valuable patents and publishing papers in peer-reviewed journals demonstrating the effectiveness of the technology. When I spoke with her last year, she was rightly very proud of her achievements and had complete confidence in this revolutionary low temperature technology and its setting a new standard for the industry. It is my belief she left the company because the position of Chief Scientific Officer was awarded to someone new with much broader industry experience, expertice, and connections.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities